Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Maertzdorf, Jeroen ^a   Ota, Martin ^b   Repsilber, Dirk ^c   Mollenkopf, Hans J ^a   Weiner, January ^a   Hill, Philip C ^b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR 1; INTERFERON; JANUS KINASE; STAT PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FCGR1 GENE; FEMALE; GAMBIA; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SIMILARITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MALE; MICROBIAL IMMUNITY; MTB GENE; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION INITIATION; TUBERCULOSIS; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNITY; METABOLISM; MULTIGENE FAMILY;

CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIGENE FAMILY; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 80055042377     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026938     Document Type: Article

References (24)

1. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, et al. (2011) The BCG world atlas: A database of global BCG vaccination policies and practices. PloS Medicine 8: e1001012.
2. Chaussabel D, Pascual V, Banchereau J, (2010) Assessing the human immune system through blood transcriptomics. BMC Biology 8: 84.
3. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85: 613-621.
4. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, et al. (2007) Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195: 357-365.
5. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
6. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
7. Parida SK, Kaufmann SH, (2010) The quest for biomarkers in tuberculosis. Drug Discov Today 15: 148-157.
8. Zárate-Bladés CR, Silva CL, Passos GA, (2011) The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy. Clin Dev Immunol 2011: 192630 Epub 2010 Dec 20.
9. Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner A, et al. (2010) Suppressor of cytokine signaling (SOCS)-3 is affected in T cells from TB patients. Clin Microbiol Inf 17: 1323-1331.
10. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2005) Ras-associated small GTPase 33A, a novel T cell factor, is down-regulated in patients with Tuberculosis. J Inf Dis 192: 1211-1218.
11. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z, (2009) GOrilla: A Tool For Discovery And Visualization of Enriched GO Terms in Ranked Gene Lists. BMC Bioinformatics 10: 48.
12. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, et al. (2009) A novel signaling pathway impact analysis. Bioinformatics 25: 75-82.
13. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(Database issue):D561-8. Epub 2010 Nov 2.
14. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
15. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, et al. (2010) Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.
16. McNerney R, Daley P, (2011) Towards a point-of-care test for active tuberculosis: obstacles and ooportunities. Nat Rev Microbiol 9: 204-213.
17. Doherty M, Wallis RS, Zumla A, WHO-Tropical Disease Research/European Commission joint expert consultation group (2009) Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med 15: 181-187.
18. Obermoser G, Pascual V, (2010) The interferon-alpha signature of systemic lupus erythematosus. Lupus 19: 1012-1019.
19. Kyogoku C, Tsuchiya N, (2007) A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 8: 445-455.
20. Senbagavalli P, Geetha ST, Venkatesan P, Ramanathan VD, (2009) Defective solubilization of immune complexes and activation of the complement system in patients with pulmonary tuberculosis. J Clin Immunol 29: 674-680.
21. Ramanathan VD, Tyagi P, Ramanathan U, Katoch K, Sengupta U, et al. (1991) Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions. Int J Lepr Other Mycobact Dis 59: 5-11.
22. Alexander WS, Hilton DJ, (2004) The role of suppressors of cytokine signaling (socs) proteins in regulation of the immune response. Annu Rev Immunol 22: 503-529.
23. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, et al. (2008) Putting out the fire: Coordinated suppression of the innate and adaptive immune systems by socs1 and socs3 proteins. Immunol Rev 224: 265-283.
24. Davis AE, (2004) Biological effects of C1 inhibitor. Drug News Perspect 17: 439-46.